Mounjaro is expected to become a blockbuster treatment if it is also approved to treat obesity and a U.S. decision on its use for weight loss is expected later this year. Bloomberg News quoted Helen Knight, director of medicines evaluation at the National Institute for Health and Care Excellence (NICE) as saying that Mounjaro has the potential to "provide an effective and good value treatment option" for people with type 2 diabetes that isn't well controlled by other drugs.

Related Keywords

Bengaluru , Karnataka , India , United Kingdom , Britain , Lavanya Ahire , Edwina Gibbs , Helen Knight , Eli Lilly , Reuters , National Institute For Health , National Health Service , Bloomberg News , National Institute , Care Excellence , National Health , Diabetes Treatment , National Institute For Health And Care Excellence , Weight Loss , Type 2 Diabetes ,